clinical trials of monoclonal antibodies to produce covid-19 now enrolling
clinical trials of monoclonal antibodies to produce covid-19 now enrolling
this network will allow us to test the safety and efficacy of monoclonal antibodies and other preventive measures to help identify how best to reduce the level of sars-cov-2 infection and ultimately end the covid-19 pandemic. monoclonal antibodies are laboratory-made versions of proteins naturally produced by the immune system in response to invading viruses or other pathogens.